<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898934</url>
  </required_header>
  <id_info>
    <org_study_id>Lean Vitamin D</org_study_id>
    <nct_id>NCT03898934</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in Lean PCOS Patients</brief_title>
  <acronym>Leanvit-D</acronym>
  <official_title>Dose Vitamin D Supplementation in Lean Patients With Polycystic Ovary Syndrome Improves Ovulation and Pregnancy Rates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess whether Vitamin D supplementations for lean patients with polycystic ovary syndrome
      in conjunction with clomiphene citrate are beneficial or not
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is double blinded randomized controlled study conducted at Tanta University
      hospitals in the period from September 2017 to December 2018. Patients and methods: One
      hundred twelve patients were recruited and randomly allocated into 2 groups; study group with
      Vitamin D supplementation and control group without Vitamin D supplementation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The 2 groups will be treated at the same time</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Both patients and gynecologists were binded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Ovulation rate</measure>
    <time_frame>3 months</time_frame>
    <description>Number of mature follicles obtained</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>3 months</time_frame>
    <description>Number of patients who get pregnant</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>Vitamin D group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients will receive 6000IU daily for 8 weeks then 2000IU maintenance till pregnancy or end of study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>These group will receive placebo for the same periods of study group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>receive 6000iu daily for 8 weeks</description>
    <arm_group_label>Vitamin D group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>placebo for the same period</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lean

          -  PCOS

          -  Infertile

          -  Vitamin D deficient

        Exclusion Criteria:

          -  Age less than 20 and more than 35

          -  Non PCOS patients

          -  Obese patients

          -  Previous ovarian surgery

          -  Previous oophrectomy of one ovary
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ayman Dawood, MD</last_name>
    <phone>+201020972067</phone>
    <email>ayman.dawood@med.tanta.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adel Elgergawy, MD</last_name>
    <phone>+201002057250</phone>
    <email>dradelali775@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ayman Shehata Dawood</name>
      <address>
        <city>Tanta</city>
        <state>Algharbia</state>
        <zip>31111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Elhalwagy, MD</last_name>
      <phone>+201020972067</phone>
      <email>halwagy22@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hesham Salem, MD</last_name>
      <phone>+20122348805</phone>
      <email>prof.hesham_salem@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ayman Shehata Dawood</name>
      <address>
        <city>Tanta</city>
        <state>Algharbia</state>
        <zip>31111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salah Naglah, MD</last_name>
      <email>salahnaglah@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Adel Elgergawy, MD</last_name>
      <phone>01002057250</phone>
      <phone_ext>002</phone_ext>
      <email>dradelali775@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 30, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Ayman S Dawood, MD</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>Lean PCOS</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Supplementation</keyword>
  <keyword>Ovulation</keyword>
  <keyword>Pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The investigators will share results</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>3 months</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

